Komori
Mental Health Technologies (9218) · TargetRaised

Achieving Consolidated Revenue of ¥10 Billion and Operating Profit of ¥2.0–2.5 Billion Under Medium-Term Management Plan MHT100/20-25

First written in FY2024-Q1. 3 of 7 entries say "Restated". Latest entry: FY2026-H1.

7entries
3years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2024-Q1 – FY2025Raised2026-05-15 – FY2026-H12024: 220242025: 120252026: 42026
Same theme, other companies
Setting and achieving performance targets under the medium-term management planA theme 791 companies write about · 75 as a headwind · 1062 as a tailwind

The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 133 companies compared. The sentences above are computed from all 133.Comparing 200 of the theme's 1182 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RaisedAnnual report

    「In light of the acquisition of new subsidiaries and progress in each business, we revised the medium-term management plan “MHT100/20-25,” formulated for the fiscal year ending December 2027 with targets of consolidated revenue of ¥10 billion and operating profit of ¥2.0–2.5 billion. First, the target year was postponed by 1 year to the fiscal year ending December 2028, and the consolidated revenue target was raised from ¥10 billion to ¥15 billion. The operating profit target was set at ¥2.0 billion, the lower end of the previous plan, to ensure steady achievement in light of last year’s downward revision to the earnings forecast. These targets are based solely on organic growth from the existing 2 growth engines and do not include possible business expansion through future acquisitions.」

    The medium-term target year was postponed from the fiscal year ending December 2027 to December 2028, while the consolidated revenue target increased from ¥10 billion to ¥15 billion. The operating profit target changed from ¥2.0–2.5 billion to ¥2.0 billion, making the revenue target more ambitious while extending the timeframe and reducing the profit target.
  2. FY2025RestatedAnnual report

    「Our group formulated plans for the current consolidated fiscal year with a view to further growth toward achieving the medium-term management plan “MHT100/20-25,” formulated for the fiscal year ending December 2027 with targets of consolidated revenue of ¥10 billion and operating profit of ¥2.0–2.5 billion.」

    The company maintained the targets for the fiscal year ending December 2027. Although it revised its full-year forecast downward in Q3 FY2025, no change to the medium-term targets was disclosed.
  3. FY2025-H1RestatedAnnual report

    「In these circumstances, our group took measures to achieve the medium-term management plan “MHT100/20-25,” formulated for the fiscal year ending December 2027 with targets of consolidated revenue of ¥10 billion and operating profit of ¥2.0–2.5 billion.」

    The company reaffirmed the medium-term targets and the measures taken to achieve them.
  4. FY2024-H1RestatedAnnual report

    「Based on this, we formulated and announced the medium-term management plan “MHT100/20-25” in the disclosure of “Information on Business Plans and Matters Concerning Growth Potential” published on 27 March 2024. The plan identifies the mental health solutions business and the medical work shift business as two growth engines and targets consolidated revenue of ¥10 billion and operating profit of ¥2.0–2.5 billion for the fiscal year ending December 2027.」

    The company reaffirmed the medium-term targets of 2 growth engines, consolidated revenue of ¥10 billion and operating profit of ¥2.0–2.5 billion for the fiscal year ending December 2027.
  5. FY2024-Q1First statedAnnual report

    「Based on this, we formulated and announced the medium-term management plan “MHT100/20-25” in the disclosure of “Information on Business Plans and Matters Concerning Growth Potential” published on 27 March 2024. The plan identifies the mental health solutions business and the medical work shift business as two growth engines and targets consolidated revenue of ¥10 billion and operating profit of ¥2.0–2.5 billion for the fiscal year ending December 2027.」

    The company first disclosed the medium-term management plan targeting consolidated revenue of ¥10 billion and operating profit of ¥2.0–2.5 billion for the fiscal year ending December 2027, with the mental health solutions and medical work shift businesses as its 2 growth engines.
Moved together

"Creating a Well-Being Standard and Solving Physical and Mental Health Issues" moved the same way as this thread, in the same document, in 2 of its 7 moves.

22222★12345
  1. ★This thread
  2. 1Creating a Well-Being Standard and Solving Physical and Mental Health Issues2×
  3. 2Database and Customer-Development Synergies Across the 3 Businesses2×
  4. 3Expansion into Mental Clinic Operations Support and Personal Training Gyms2×
  5. 4Expanding the Task Shifting Business Through the Acquisition of Taskforce2×
  6. 5Expanding into Return-to-Work Support and the Rework Field Through the Include Acquisition2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mental Health Technologies yet. It last moved in the Earnings of 2026-05-15: "Raised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Achieving Consolidated Revenue of ¥10 Billion and Operating Profit of ¥2.0–2.5 Billion Under Medium-Term Management Plan MHT100/20-25 | Mental Health Technologies Co.,Ltd. (9218) | Komori